๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of dyslipidemia in patients with type 2 diabetes

โœ Scribed by Vijayaraghavan, Krishnaswami (author)

Book ID
120688829
Publisher
BioMed Central
Year
2010
Tongue
English
Weight
581 KB
Volume
9
Category
Article
ISSN
1476-511X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pravastatin compared to bezafibrate in t
Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus
โœ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 2 views

Background Both HMG-CoA reductase inhibitors and ยฎbric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg bezaยฎbrate, a ยฎbric acid deriva